Furowise-Plus 20/50 Tablet

Furosemide 20 mg + Spironolactone 50 mg

Furowise-Plus 20/50 Tablet — Furosemide 20 mg + Spironolactone 50 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Furosemide 20 mg + Spironolactone 50 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 15 (Alu Alu)
MRP ₹ 795
Therapy G.P + Nephro — Loop diuretic + potassium-sparing diuretic (aldosterone antagonist)
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Furowise-Plus 20/50 Tablet

Furowise-Plus Tablet combines the loop diuretic Furosemide 20 mg with the aldosterone antagonist Spironolactone 50 mg. The pairing provides robust diuresis while preserving potassium — useful in resistant fluid overload states.

It is widely used for cirrhotic ascites, refractory oedema of nephrotic syndrome, chronic heart failure with congestion, and any state where furosemide alone produces hypokalaemia.

Camrut Healthcare manufactures Furowise-Plus under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Cirrhotic ascites
  • Refractory oedema of nephrotic syndrome
  • Chronic heart failure with congestion
  • Resistant peripheral oedema
  • Hyperaldosteronism states

Mechanism of Action

Furosemide inhibits the Na+/K+/2Cl- cotransporter in the thick ascending loop of Henle, producing potent natriuresis and water loss but also kaliuresis. Spironolactone competitively antagonises aldosterone at the distal tubule mineralocorticoid receptor, reducing sodium reabsorption and potassium loss. The combination achieves diuresis with relative potassium preservation.

Dosage & Administration

['Adults: 1 tablet once daily in the morning, or as advised', 'Reduce dose in elderly', 'Monitor electrolytes (especially potassium) and renal function periodically', 'Take with breakfast']

Side Effects

['Dehydration and electrolyte imbalance', 'Hypotension', 'Hyperkalaemia (spironolactone)', 'Gynaecomastia (long-term spironolactone)', 'Mild GI upset']

Contraindications & Precautions

['Anuria', 'Severe renal impairment', 'Hyperkalaemia', "Addison's disease", 'Pregnancy and breastfeeding (caution)']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Furowise-Plus 20/50 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.